Morgan Robert, Loh Eddie, Singh Devika, Mendizabal Isabel, Yi Soojin V
College of Computing, Georgia Institute of Technology, Atlanta, GA 30332.
School of Biological Sciences, Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA 30332.
bioRxiv. 2024 Apr 17:2024.04.16.589778. doi: 10.1101/2024.04.16.589778.
The mechanisms of X chromosome inactivation suggest fundamental epigenetic differences between the female and male X chromosomes. However, DNA methylation studies often exclude the X chromosomes. In addition, many previous studies relied on techniques that examine non-randomly selected subsets of positions such as array-based methods, rather than assessing the whole X chromosome. Consequently, our understanding of X chromosome DNA methylation lags behind that of autosomes. Here we addressed this gap of knowledge by studying X chromosome DNA methylation using 89 whole genome bisulfite sequencing (WGBS) maps from neurons and oligodendrocytes. Using this unbiased and comprehensive data, we show that DNA methylation of the female X chromosomes is globally reduced (hypomethylated) across the entire chromosome compared to the male X chromosomes and autosomes. On the other hand, the majority of X-linked promoters were more highly methylated (hypermethylated) in females compared to males, consistent with the role of DNA methylation in X chromosome inactivation and dosage compensation. Remarkably, hypermethylation of female X promoters was limited to a group of previously lowly methylated promoters. The other group of highly methylated promoters were both hyper- and hypo-methylated in females with no obvious association with gene expression. Therefore, X chromosome inactivation by DNA methylation was exclusive to a subset of promoters with distinctive epigenetic feature. Apart from this group of promoters, differentially methylated regions in the female and male X chromosomes were dominated by female hypomethylation. Our study furthers the understanding of X-chromosome dosage regulation by DNA methylation on the chromosomal level as well as on individual gene level.
X染色体失活的机制表明,雌性和雄性X染色体之间存在着根本的表观遗传差异。然而,DNA甲基化研究通常将X染色体排除在外。此外,许多先前的研究依赖于检查非随机选择的位置子集的技术,如基于阵列的方法,而不是评估整个X染色体。因此,我们对X染色体DNA甲基化的理解落后于常染色体。在这里,我们通过使用来自神经元和少突胶质细胞的89个全基因组亚硫酸氢盐测序(WGBS)图谱研究X染色体DNA甲基化,填补了这一知识空白。利用这些无偏差且全面的数据,我们发现,与雄性X染色体和常染色体相比,雌性X染色体的DNA甲基化在整个染色体上整体降低(低甲基化)。另一方面,与雄性相比,大多数X连锁启动子在雌性中甲基化程度更高(高甲基化),这与DNA甲基化在X染色体失活和剂量补偿中的作用一致。值得注意的是,雌性X启动子的高甲基化仅限于一组先前甲基化程度较低的启动子。另一组高度甲基化的启动子在雌性中既有高甲基化也有低甲基化,与基因表达没有明显关联。因此,DNA甲基化介导的X染色体失活仅限于具有独特表观遗传特征的启动子子集。除了这组启动子外,雌性和雄性X染色体上的差异甲基化区域主要由雌性低甲基化主导。我们的研究在染色体水平以及单个基因水平上进一步加深了对DNA甲基化介导的X染色体剂量调控的理解。